A pdf for the benchmark trial is downloadable from this page:
https://www.researchgate.net/public...asound_in_the_management_of_venous_leg_ulcers
I have had a good read through it and see no two week screening like our trial.
So as you state Werble, the placebo in our trial (which is what our drug will be compared against) is likely to have a much lower healing rate than the benchmark study quoted in the presentation - as those easy healers were screened out.
So the trial results could be pretty fantastic!
Cross those fingers!
ps. bare in mind that the benchmark quoted is a subset from the VenUS iii trial
- Forums
- ASX - By Stock
- DLM
- run coming?
run coming?, page-56
-
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online